½ÃÀ庸°í¼­
»óǰÄÚµå
1711608

ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå ºÐ¼® ¹× ¿¹Ãø(-2034³â) : À¯Çü, Á¦Ç°, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ÇÁ·Î¼¼½º, Àü°³, ±â´É, ÇüÅÂ, ´Ü°è

Influenza Vaccine Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Process, Deployment, Functionality, Mode, Stage

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Insight Services | ÆäÀÌÁö Á¤º¸: ¿µ¹® 334 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº 2024³â 82¾ï ´Þ·¯¿¡¼­ 2034³â±îÁö 145¾ï ´Þ·¯·Î È®´ëµÇ¾î ¿¬Æò±Õ ¾à 5.9%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â °øÁߺ¸°Ç¿¡ ÇʼöÀûÀÎ ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ¹é½ÅÀÇ °³¹ß, Á¦Á¶, À¯ÅëÀÌ Æ÷ÇԵ˴ϴÙ. °èÀý¼º µ¶°¨ À¯Çà, Á¤ºÎÀÇ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥, °è¶õ ±â¹Ý ¹× ¼¼Æ÷ ±â¹Ý Á¦Á¶¹ýÀ» Æ÷ÇÔÇÑ ¹é½Å ±â¼úÀÇ ¹ßÀüÀÌ ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¹é½ÅÀÇ È¿´É°ú Á¢±Ù¼º Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃá ÀνÄÀÇ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±ÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä

ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº ´Ù¾çÇÑ ºÎ¹®À¸·Î Ư¡Áö¾îÁö¸ç °ß°íÇÑ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼ºÀÎ ºÎ¹®Àº ÀÎÇ÷翣ÀÚ°¡ °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¼ºÀÎ Àα¸ÀÇ ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥ äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÁÖ¿ä ºÎ¹®À¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ¹é½Å Á¢Á¾·üÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎÀÇ ³ë·Â°ú ±¤¹üÀ§ÇÑ ¿¹¹æ È¿°ú¸¦ Á¦°øÇϴ ÷´Ü ¹é½ÅÀÇ °³¹ß·Î ÀÎÇØ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. ¼Ò¾Æ ºÎ¹®Àº ±Ô¸ð´Â ÀÛÁö¸¸, ºÎ¸ðµéÀÇ ÀÎ½Ä Á¦°í¿Í ¾î¸°À̸¦ ´ë»óÀ¸·Î ÇÑ °øÁߺ¸°Ç Ä·ÆäÀÎÀ¸·Î ÀÎÇØ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. »õ·Î¿î ÇÏÀ§ ºÎ¹®À¸·Î 4°¡ ¹é½ÅÀº 4Á¾·ùÀÇ ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º ±ÕÁÖ¿¡ ´ëÇÑ ¸é¿ªÀ» Á¦°øÇÏ´Â 4°¡ ¹é½ÅÀ¸·Î, ±× È¿´ÉÀÌ Çâ»óµÇ¸é¼­ Å« ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °è¶õÀ» »ç¿ëÇÏÁö ¾Ê°í »ý»êµÇ´Â ÀçÁ¶ÇÕ ¹é½ÅÀÇ µîÀåÀº °è¶õ ¾Ë·¹¸£±â°¡ ÀÖ´Â »ç¶÷µé¿¡°Ô À¯¸ÁÇÑ ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀåÀÇ ´Ù¾çÈ­¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¸¦ Á¾ÇÕÇØ º¼ ¶§, ½ÃÀå »óȲÀº ¿ªµ¿ÀûÀ̸ç, Áö¼ÓÀûÀÎ È®´ë¿Í Çõ½ÅÀÌ ¿¹»óµË´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­
À¯Çü 3°¡ ¹é½Å, 4°¡ ¹é½Å
Á¦Ç°¼Ò°³ ºÒȰ¼ºÈ­ ¹é½Å, Ȱ¼ºÈ­ ¹é½Å, À¯ÀüÀÚ º¯Çü ¹é½Å, À¯ÀüÀÚÀçÁ¶ÇÕ ¹é½Å
±â¼ú ³­ÀÚ ±â¹Ý, ¼¼Æ÷ ±â¹Ý, ÀçÁ¶ÇÕ DNA
¿ëµµ ¼Ò¾Æ, ¼ºÀÎ, ³ëÀÎ, ÀÓ»êºÎ
ÃÖÁ¾»ç¿ëÀÚ º´¿ø, Ŭ¸®´Ð, ¾à±¹, Ä¿¹Â´ÏƼ ¼¾ÅÍ, ¿¬±¸ ±â°ü
ÇÁ·Î¼¼½º Á¦Á¶, À¯Åë, º¸°ü
Àü°³ ¿ÂÇÁ·¹¹Ì½º, Ŭ¶ó¿ìµå ±â¹Ý
±â´É¼º ¸é¿ª¿ø¼º, ¾ÈÀü¼º, À¯È¿¼º
¸ðµå ±ÙÀ° ³», ºñ°­ ³», ÇǺΠ³»
´Ü°è ÀüÀÓ»ó½ÃÇè, ÀÓ»ó½ÃÇè, ½ÃÆÇ ÈÄ Á¶»ç

ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº ÁÖ·Î ºÒȰ¼ºÈ­ ¹é½Å ºÎ¹®ÀÌ ÁÖµµÇϰí ÀÖÁö¸¸, ¾àµ¶¼º »ý¹é½Åµµ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼¼ºÐÈ­´Â À¯È¿¼º, ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏ, ´Ù¾çÇÑ Àα¸ Áý´ÜÀÇ ´Ù¾çÇÑ ¿ä±¸¿Í °°Àº ¿äÀο¡ ÀÇÇØ ¿µÇâÀ» ¹Þ½À´Ï´Ù. Áö¿ªº°·Î º¸¸é ºÏ¹Ì´Â źźÇÑ ÀÇ·á ÀÎÇÁ¶ó¿Í ÀÎ½Ä °³¼± ÇÁ·Î±×·¥À¸·Î ÀÎÇØ ¼±µÎ¸¦ À¯ÁöÇϰí ÀÖÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾çÀº Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÇ·á ÅõÀÚ Áõ°¡·Î ÀÎÇØ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

Sanofi, GlaxoSmithKline, CSL Limited µî ¾÷°è ¼±µÎÁÖÀÚµéÀº ¿¬±¸°³¹ßÀ» ÅëÇØ Áö¼ÓÀûÀ¸·Î Æ÷Æ®Æú¸®¿À¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹°ú À¯·´ÀÇ ±ÔÁ¦ ¿µÇâÀº ¸Å¿ì Å©¸ç, ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀÌ ¹é½ÅÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÏ°í ½ÃÀåÀÇ ¿ªµ¿¼ºÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ÇâÈÄ ¹é½Å »ý»ê ¹× À¯ÅëÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ½ÃÀåÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü¿°º´¿¡ ´ëÇÑ ´ëºñ¿Í ¸¸´É ¹é½Å °³¹ß¿¡ ÁßÁ¡À» µÎ¾î À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª °ø±Þ¸Á ¹°·ù, ¹é½Å¿¡ ´ëÇÑ ÁÖÀúÇÔ µî ¿©ÀüÈ÷ µµÀü°úÁ¦°¡ ³²¾ÆÀÖ¾î ¼ºÀåÀ» À¯ÁöÇϱâ À§ÇÑ Àü·«Àû °³ÀÔÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ:

ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº °¨¿°¼º Áúȯ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¹é½Å Á¢Á¾ÀÇ Á߿伺ÀÌ ºÎ°¢µÇ¸é¼­ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±¤¹üÀ§ÇÑ ¿¹¹æ È¿°ú¿Í ±ä ¸é¿ª Áö¼Ó½Ã°£À» °¡Áø Â÷¼¼´ë ¹é½ÅÀÇ °³¹ßÀÌ ÀÖ½À´Ï´Ù. ¼¼Æ÷ ±â¹Ý ±â¼ú, À¯ÀüÀÚ ÀçÁ¶ÇÕ ±â¼ú µî ¹é½Å Á¦Á¶ÀÇ ±â¼ú ¹ßÀüÀº Á¦Á¶ °øÁ¤À» °£¼ÒÈ­ÇÏ°í ¹é½ÅÀÇ È¿´ÉÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀº °øÁߺ¸°Ç¿¡¼­ ¹é½ÅÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ºÎ°¢½ÃÄ×°í, ¹é½Å ¿¬±¸¿Í ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¸¦ Áõ°¡½ÃÄ×½À´Ï´Ù. °¢±¹ Á¤ºÎ´Â Á¾ÇÕÀûÀÎ ÆÒµ¥¹Í ´ëÀÀ Àü·«ÀÇ ÀÏȯÀ¸·Î µ¶°¨ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥À» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹ÀÇ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥ È®´ë´Â ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ƯÁ¤ Áý´Ü¿¡ ¸Â´Â ¸ÂÃãÇü ¹é½Å¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¹é½Å Á¢Á¾·ü°ú È¿´ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀÇ È¿À²ÀûÀÎ ¹èÆ÷¿Í ¸ð´ÏÅ͸µÀ» ÃËÁøÇÏ´Â µðÁöÅÐ Çコ Ç÷§Æû¿¡´Â ¸¹Àº ±âȸ°¡ ÀÖ½À´Ï´Ù. ÁÖ»ç¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â ¿É¼Ç µî ¹é½Å Àü´Þ ¹æ½ÄÀ» Çõ½ÅÇÏ´Â ±â¾÷µéÀº Å« ½ÃÀå Á¡À¯À²À» È®º¸ÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ ÀâÀ» ¼ö ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº °èÀý¼º µ¶°¨ ¹× ÀáÀçÀûÀÎ ´ëÀ¯Ç༺ µ¶°¨ À§Çù¿¡ ´ëÀÀÇÏ¿© Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾ïÁ¦¿äÀΰú °úÁ¦:

ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº ¸î °¡Áö Áß¿äÇÑ ½ÃÀå ¾ïÁ¦¿äÀΰú µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. °¡Àå Å« ¿ì·Á´Â µ¶°¨ÀÇ °èÀýÀû Ư¼ºÀ¸·Î ÀÎÇØ ¼ö¿ä º¯µ¿ÀÌ ¹ß»ýÇÏ¿© »ý»ê °èȹÀ» º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. À߸øµÈ Á¤º¸¿Í Á¦¾àȸ»ç¿¡ ´ëÇÑ ºÒ½ÅÀ¸·Î ÀÎÇÑ ¹é½Å¿¡ ´ëÇÑ ÁÖÀúÇÔÀÌ ½ÃÀå ħÅõ¸¦ ´õ¿í Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹é½Å ¿¬±¸°³¹ß¿¡ ¼Ò¿äµÇ´Â ³ôÀº ºñ¿ëÀº ½Å±Ô ÁøÀÔ ±â¾÷¿¡°Ô Å« À庮À¸·Î ÀÛ¿ëÇÏ¿© ±â¼ú Çõ½ÅÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ±î´Ù·Î¿î ½ÂÀÎ °úÁ¤°ú °°Àº ±ÔÁ¦Àû Àå¾Ö¹°ÀÌ »õ·Î¿î ¹é½ÅÀÇ ½ÃÀå Ãâ½Ã¸¦ Áö¿¬½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ·¯½ºÀÇ ±Þ¼ÓÇÑ º¯ÀÌ¿¡ ´ëÀÀÇϱâ À§ÇØ ¹é½Å ±ÕÁÖ¸¦ Áö¼ÓÀûÀ¸·Î ¾÷µ¥ÀÌÆ®ÇØ¾ß Çϱ⠶§¹®¿¡ Á¦Á¶¾÷ü´Â Áö¼ÓÀûÀÎ ÀçÁ¤Àû, ¹°·ùÀû ºÎ´ãÀ» ¾È°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦µéÀº Á¾ÇÕÀûÀ¸·Î ½ÃÀå ¼ºÀå°ú Á¢±Ù¼ºÀ» ÀúÇØÇϰí ÀÎÇ÷翣ÀÚ ¹ß»ýÀ» ¾ïÁ¦Çϱâ À§ÇÑ °øÁߺ¸°Ç ³ë·Â¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå °³¿ä

  • Á¶»ç ¸ñÀû
  • ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå Á¤ÀÇ¿Í Á¶»ç ¹üÀ§
  • º¸°í¼­ Á¦ÇÑ»çÇ×
  • Á¶»ç ´ë»ó ¿¬µµ¿Í ÅëÈ­
  • Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®

Á¦4Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå Àü¸Á

  • ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå ¼¼ºÐÈ­
  • ½ÃÀå ¿ªÇÐ
  • Porter's Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • 4P ¸ðµ¨
  • ANSOFF ¸ÅÆ®¸¯½º

Á¦5Àå ÀÎÇ÷翣ÀÚ ¹é½Å ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå Àü·«

  • »óºÎ ½ÃÀå ºÐ¼®
  • ¼ö±Þ ºÐ¼®
  • ¼ÒºñÀÚ ±¸¸Å ÀÇ¿å
  • »ç·Ê ¿¬±¸ ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • °ø±Þ¸Á ºÐ¼®
  • °æÀï Á¦Ç° ºÐ¼®
  • ÃÖ±Ù µ¿Çâ

Á¦6Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå ±Ô¸ð

  • ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå ±Ô¸ð : ±Ý¾×º°
  • ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå ±Ô¸ð : ¼ö·®º°

Á¦7Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : À¯Çüº°

  • ½ÃÀå °³¿ä
  • 3°¡ ¹é½Å
  • 4°¡ ¹é½Å
  • ±âŸ

Á¦8Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå °³¿ä
  • ºÒȰȭ ¹é½Å
  • »ý ¹é½Å
  • ÀçÁ¶ÇÕ ¹é½Å
  • ±âŸ

Á¦9Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ±â¼úº°

  • ½ÃÀå °³¿ä
  • °è¶õ ±â¹Ý
  • ¼¼Æ÷ ±â¹Ý
  • ÀçÁ¶ÇÕ DNA
  • ±âŸ

Á¦10Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ¿ëµµº°

  • ½ÃÀå °³¿ä
  • ¼Ò¾Æ
  • ¼ºÀÎ
  • ³ëÀÎ
  • ÀÓ»êºÎ
  • ±âŸ

Á¦11Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå °³¿ä
  • º´¿ø
  • Áø·á¼Ò
  • ¾à±¹
  • Ä¿¹Â´ÏƼ ¼¾ÅÍ
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦12Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ÇÁ·Î¼¼½ºº°

  • ½ÃÀå °³¿ä
  • Á¦Á¶
  • À¯Åë
  • º¸°ü
  • ±âŸ

Á¦13Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : Àü°³º°

  • ½ÃÀå °³¿ä
  • ¿ÂÇÁ·¹¹Ì½º
  • Ŭ¶ó¿ìµå ±â¹Ý
  • ±âŸ

Á¦14Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ±â´Éº°

  • ½ÃÀå °³¿ä
  • ¸é¿ª¿ø¼º
  • ¾ÈÀü¼º
  • À¯È¿¼º
  • ±âŸ

Á¦15Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : Çüź°

  • ½ÃÀå °³¿ä
  • ±ÙÀ°³» Åõ¿©
  • °æºñ
  • Çdz» Åõ¿©
  • ±âŸ

Á¦16Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ´Ü°èº°

  • ½ÃÀå °³¿ä
  • ÀüÀÓ»ó½ÃÇè
  • ÀÓ»ó½ÃÇè
  • ½ÃÆÇ ÈÄ Á¶»ç
  • ±âŸ

Á¦17Àå ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • ½ºÀ§½º
    • µ§¸¶Å©
    • Çɶõµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ½Ì°¡Æ÷¸£
    • Àεµ³×½Ã¾Æ
    • ´ë¸¸
    • ¸»·¹À̽þÆ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦18Àå °æÀï ±¸µµ

  • °³¿ä
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ Æ÷Áö¼Å´×
  • °æÀï ¸®´õ½Ê ¸ÅÇÎ
  • º¥´õ º¥Ä¡¸¶Å·
  • °³¹ß Àü·« º¥Ä¡¸¶Å·

Á¦19Àå ±â¾÷ °³¿ä

  • Seqirus
  • Sanofi Pasteur
  • GlaxoSmithKline
  • AstraZeneca
  • BioDiem
  • FluGen
  • Novavax
  • Medicago
  • Bharat Biotech
  • Serum Institute of India
  • Sinovac Biotech
  • CureVac
  • Moderna
  • Inovio Pharmaceuticals
  • Altimmune
  • Vaxart
  • Dynavax Technologies
  • Valneva
  • Emergent BioSolutions
  • CSL Limited
ksm

Influenza Vaccine Market is anticipated to expand from $8.2 billion in 2024 to $14.5 billion by 2034, growing at a CAGR of approximately 5.9%. The market encompasses the development, production, and distribution of vaccines targeting influenza viruses, crucial for public health. This market is driven by seasonal flu outbreaks, governmental immunization programs, and advancements in vaccine technology, including egg-based and cell-based production methods. Increasing awareness and healthcare infrastructure improvements are propelling market growth, with a focus on enhancing vaccine efficacy and accessibility.

Market Overview

The Influenza Vaccine Market is characterized by distinct segments, each contributing to its robust growth. The adult segment emerges as the leading segment, primarily driven by heightened awareness of influenza's health implications and the increasing adoption of vaccination programs among the adult population. This dominance is further bolstered by government initiatives aimed at enhancing vaccine coverage and the development of advanced vaccines offering broader protection. The pediatric segment, while smaller, is gaining momentum due to growing parental awareness and public health campaigns targeting children. Emerging sub-segments include quadrivalent vaccines, which provide immunity against four influenza virus strains, demonstrating significant potential due to their enhanced efficacy. Additionally, the rise of recombinant vaccines, which are produced without the use of eggs, offers a promising alternative for those with egg allergies and contributes to the market's diversification. These trends collectively underscore a dynamic market landscape poised for continued expansion and innovation.

Market Segmentation
TypeTrivalent Vaccines, Quadrivalent Vaccines
ProductInactivated Vaccine, Live Attenuated Vaccine, Recombinant Vaccine
TechnologyEgg-based, Cell-based, Recombinant DNA
ApplicationPediatrics, Adults, Elderly, Pregnant Women
End UserHospitals, Clinics, Pharmacies, Community Centers, Research Institutes
ProcessManufacturing, Distribution, Storage
DeploymentOn-premise, Cloud-based
FunctionalityImmunogenicity, Safety, Efficacy
ModeIntramuscular, Intranasal, Intradermal
StagePre-clinical, Clinical Trials, Post-marketing Surveillance

The influenza vaccine market is predominantly driven by the inactivated vaccine segment, with live attenuated vaccines also maintaining a significant presence. This segmentation is influenced by factors such as efficacy, safety profiles, and the varying needs of different demographic groups. Geographically, North America remains at the forefront due to robust healthcare infrastructure and awareness programs, while the Asia-Pacific region is witnessing a burgeoning demand fueled by increasing government initiatives and rising healthcare investments.

Prominent industry players, including Sanofi, GlaxoSmithKline, and CSL Limited, are continuously enhancing their portfolios through research and development. Regulatory influences, particularly in the United States and Europe, are pivotal, as stringent guidelines ensure vaccine safety and efficacy, thereby shaping market dynamics. Looking ahead, the market is anticipated to expand due to technological advancements in vaccine production and distribution. The ongoing emphasis on pandemic preparedness and the development of universal vaccines present lucrative opportunities. However, challenges such as supply chain logistics and vaccine hesitancy remain, necessitating strategic interventions to sustain growth.

Recent Developments:

The influenza vaccine market has experienced noteworthy developments over the past three months. Sanofi announced a strategic partnership with a leading biotech firm to enhance its flu vaccine production capabilities, aiming to address global demand surges. GlaxoSmithKline (GSK) launched an innovative flu vaccine in Europe, featuring enhanced efficacy against emerging strains, marking a significant milestone in vaccine technology. In the United States, the Food and Drug Administration (FDA) granted fast-track approval for a novel influenza vaccine developed by a prominent pharmaceutical company, promising quicker market entry. Meanwhile, a joint venture between a Japanese pharmaceutical giant and a European counterpart was formed to explore advanced mRNA technologies for flu vaccines, signaling a shift towards cutting-edge vaccine solutions. Furthermore, a leading vaccine manufacturer announced a substantial investment in expanding its supply chain infrastructure, ensuring robust distribution capabilities ahead of the upcoming flu season. These developments underscore the dynamic nature of the influenza vaccine market, driven by innovation and strategic collaborations.

Key Trends and Drivers:

The Influenza Vaccine Market is experiencing robust growth, driven by heightened awareness of infectious diseases and the importance of vaccination. Key trends include the development of next-generation vaccines, which offer broader protection and longer-lasting immunity. Technological advancements in vaccine production, such as cell-based and recombinant technologies, are streamlining manufacturing processes and enhancing vaccine efficacy.

The COVID-19 pandemic has underscored the critical role of vaccines in public health, leading to increased investments in vaccine research and infrastructure. Governments worldwide are prioritizing influenza vaccination programs as part of comprehensive pandemic preparedness strategies. Additionally, the expansion of immunization programs in emerging economies is significantly contributing to market growth.

There is a growing emphasis on personalized vaccines tailored to specific populations, enhancing vaccine uptake and effectiveness. Opportunities abound in digital health platforms, which facilitate efficient distribution and monitoring of vaccination campaigns. Companies that innovate in vaccine delivery methods, such as needle-free options, are poised to capture significant market share. With continuous advancements in biotechnology, the Influenza Vaccine Market is set for sustained expansion, addressing both seasonal influenza and potential pandemic threats.

Restraints and Challenges:

The influenza vaccine market is confronted with several significant restraints and challenges. A primary concern is the seasonality of influenza, which causes fluctuating demand and complicates production planning. Vaccine hesitancy, fueled by misinformation and distrust in pharmaceutical companies, further limits market penetration. Additionally, the high cost of vaccine research and development presents a significant barrier to entry for new players, stifling innovation. Regulatory hurdles, including stringent approval processes, delay the introduction of new vaccines to the market. Moreover, the need for constant updates to the vaccine strains, in response to the virus's rapid mutation, imposes a continuous financial and logistical burden on manufacturers. These challenges collectively hinder the market's growth and accessibility, impacting public health efforts to control influenza outbreaks.

Key Companies:

Seqirus, Sanofi Pasteur, Glaxo Smith Kline, Astra Zeneca, Bio Diem, Flu Gen, Novavax, Medicago, Bharat Biotech, Serum Institute of India, Sinovac Biotech, Cure Vac, Moderna, Inovio Pharmaceuticals, Altimmune, Vaxart, Dynavax Technologies, Valneva, Emergent Bio Solutions, CSL Limited

Sources:

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), European Centre for Disease Prevention and Control (ECDC), Global Alliance for Vaccines and Immunization (GAVI), United Nations Children's Fund (UNICEF), The Bill & Melinda Gates Foundation, The Sabin Vaccine Institute, The International Vaccine Institute (IVI), The Global Influenza Surveillance and Response System (GISRS), The International Society for Influenza and other Respiratory Virus Diseases (ISIRV), The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), The World Bank, The World Economic Forum, The World Organisation for Animal Health (OIE), The Coalition for Epidemic Preparedness Innovations (CEPI), The Vaccine Confidence Project (VCP), The International Conference on Influenza Vaccines for the World (IVW), The European Society of Clinical Microbiology and Infectious Diseases (ESCMID), The American Society for Microbiology (ASM)

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Influenza Vaccine Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Influenza Vaccine Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Deployment
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by Mode
  • 2.12 Key Highlights of the Market, by Stage
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Deployment
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by Mode
  • 3.11 Market Attractiveness Analysis, by Stage
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Influenza Vaccine Market Outlook

  • 4.1 Influenza Vaccine Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Influenza Vaccine Influenza Vaccine Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Influenza Vaccine Market Size

  • 6.1 Influenza Vaccine Market Size, by Value
  • 6.2 Influenza Vaccine Market Size, by Volume

7: Influenza Vaccine Market, by Type

  • 7.1 Market Overview
  • 7.2 Trivalent Vaccines
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Quadrivalent Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Influenza Vaccine Market, by Product

  • 8.1 Market Overview
  • 8.2 Inactivated Vaccine
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Live Attenuated Vaccine
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Recombinant Vaccine
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: Influenza Vaccine Market, by Technology

  • 9.1 Market Overview
  • 9.2 Egg-based
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Cell-based
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Recombinant DNA
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Influenza Vaccine Market, by Application

  • 10.1 Market Overview
  • 10.2 Pediatrics
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Adults
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Elderly
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Pregnant Women
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Influenza Vaccine Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Pharmacies
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Community Centers
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Research Institutes
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Influenza Vaccine Market, by Process

  • 12.1 Market Overview
  • 12.2 Manufacturing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Distribution
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Storage
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Influenza Vaccine Market, by Deployment

  • 13.1 Market Overview
  • 13.2 On-premise
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Cloud-based
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Influenza Vaccine Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Immunogenicity
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Safety
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Efficacy
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Influenza Vaccine Market, by Mode

  • 15.1 Market Overview
  • 15.2 Intramuscular
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Intranasal
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Intradermal
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Influenza Vaccine Market, by Stage

  • 16.1 Market Overview
  • 16.2 Pre-clinical
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Clinical Trials
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Post-marketing Surveillance
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Influenza Vaccine Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Process
    • 17.2.8 North America Market Size and Forecast, by Deployment
    • 17.2.9 North America Market Size and Forecast, by Functionality
    • 17.2.10 North America Market Size and Forecast, by Mode
    • 17.2.11 North America Market Size and Forecast, by Stage
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Process
      • 17.2.9.7 United States Market Size and Forecast, by Deployment
      • 17.2.9.8 United States Market Size and Forecast, by Functionality
      • 17.2.9.9 United States Market Size and Forecast, by Mode
      • 17.2.9.10 United States Market Size and Forecast, by Stage
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Process
      • 17.2.10.7 Canada Market Size and Forecast, by Deployment
      • 17.2.10.8 Canada Market Size and Forecast, by Functionality
      • 17.2.10.9 Canada Market Size and Forecast, by Mode
      • 17.2.10.10 Canada Market Size and Forecast, by Stage
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Process
    • 17.3.8 Europe Market Size and Forecast, by Deployment
    • 17.3.9 Europe Market Size and Forecast, by Functionality
    • 17.3.10 Europe Market Size and Forecast, by Mode
    • 17.3.11 Europe Market Size and Forecast, by Stage
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Process
      • 17.3.10.7 Germany Market Size and Forecast, by Deployment
      • 17.3.10.8 Germany Market Size and Forecast, by Functionality
      • 17.3.10.9 Germany Market Size and Forecast, by Mode
      • 17.3.10.10 Germany Market Size and Forecast, by Stage
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Process
      • 17.3.11.7 France Market Size and Forecast, by Deployment
      • 17.3.11.8 France Market Size and Forecast, by Functionality
      • 17.3.11.9 France Market Size and Forecast, by Mode
      • 17.3.11.10 France Market Size and Forecast, by Stage
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Process
      • 17.3.12.7 Spain Market Size and Forecast, by Deployment
      • 17.3.12.8 Spain Market Size and Forecast, by Functionality
      • 17.3.12.9 Spain Market Size and Forecast, by Mode
      • 17.3.12.10 Spain Market Size and Forecast, by Stage
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Process
      • 17.3.13.7 Italy Market Size and Forecast, by Deployment
      • 17.3.13.8 Italy Market Size and Forecast, by Functionality
      • 17.3.13.9 Italy Market Size and Forecast, by Mode
      • 17.3.13.10 Italy Market Size and Forecast, by Stage
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Process
      • 17.3.14.7 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.9 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.10 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Process
      • 17.3.15.7 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.9 Sweden Market Size and Forecast, by Mode
      • 17.3.15.10 Sweden Market Size and Forecast, by Stage
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Process
      • 17.3.16.7 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.9 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.10 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Process
      • 17.3.17.7 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.9 Denmark Market Size and Forecast, by Mode
      • 17.3.17.10 Denmark Market Size and Forecast, by Stage
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Process
      • 17.3.18.7 Finland Market Size and Forecast, by Deployment
      • 17.3.18.8 Finland Market Size and Forecast, by Functionality
      • 17.3.18.9 Finland Market Size and Forecast, by Mode
      • 17.3.18.10 Finland Market Size and Forecast, by Stage
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Process
      • 17.3.19.7 Russia Market Size and Forecast, by Deployment
      • 17.3.19.8 Russia Market Size and Forecast, by Functionality
      • 17.3.19.9 Russia Market Size and Forecast, by Mode
      • 17.3.19.10 Russia Market Size and Forecast, by Stage
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Process
      • 17.4.9.7 China Market Size and Forecast, by Deployment
      • 17.4.9.8 China Market Size and Forecast, by Functionality
      • 17.4.9.9 China Market Size and Forecast, by Mode
      • 17.4.9.10 China Market Size and Forecast, by Stage
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Process
      • 17.4.10.7 India Market Size and Forecast, by Deployment
      • 17.4.10.8 India Market Size and Forecast, by Functionality
      • 17.4.10.9 India Market Size and Forecast, by Mode
      • 17.4.10.10 India Market Size and Forecast, by Stage
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Process
      • 17.4.11.7 Japan Market Size and Forecast, by Deployment
      • 17.4.11.8 Japan Market Size and Forecast, by Functionality
      • 17.4.11.9 Japan Market Size and Forecast, by Mode
      • 17.4.11.10 Japan Market Size and Forecast, by Stage
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Process
      • 17.4.12.7 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.9 South Korea Market Size and Forecast, by Mode
      • 17.4.12.10 South Korea Market Size and Forecast, by Stage
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Process
      • 17.4.13.7 Australia Market Size and Forecast, by Deployment
      • 17.4.13.8 Australia Market Size and Forecast, by Functionality
      • 17.4.13.9 Australia Market Size and Forecast, by Mode
      • 17.4.13.10 Australia Market Size and Forecast, by Stage
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Process
      • 17.4.14.7 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.9 Singapore Market Size and Forecast, by Mode
      • 17.4.14.10 Singapore Market Size and Forecast, by Stage
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Process
      • 17.4.15.7 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.9 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.10 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Process
      • 17.4.16.7 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.9 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.10 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Process
      • 17.4.17.7 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.9 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.10 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Process
    • 17.5.8 Latin America Market Size and Forecast, by Deployment
    • 17.5.9 Latin America Market Size and Forecast, by Functionality
    • 17.5.10 Latin America Market Size and Forecast, by Mode
    • 17.5.11 Latin America Market Size and Forecast, by Stage
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Process
      • 17.5.9.7 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.9 Brazil Market Size and Forecast, by Mode
      • 17.5.9.10 Brazil Market Size and Forecast, by Stage
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Process
      • 17.5.10.7 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.9 Mexico Market Size and Forecast, by Mode
      • 17.5.10.10 Mexico Market Size and Forecast, by Stage
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Process
      • 17.5.11.7 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.9 Argentina Market Size and Forecast, by Mode
      • 17.5.11.10 Argentina Market Size and Forecast, by Stage
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Process
      • 17.6.10.7 UAE Market Size and Forecast, by Deployment
      • 17.6.10.8 UAE Market Size and Forecast, by Functionality
      • 17.6.10.9 UAE Market Size and Forecast, by Mode
      • 17.6.10.10 UAE Market Size and Forecast, by Stage
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Process
      • 17.6.11.7 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.9 South Africa Market Size and Forecast, by Mode
      • 17.6.11.10 South Africa Market Size and Forecast, by Stage
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Seqirus
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Sanofi Pasteur
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 GlaxoSmithKline
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 AstraZeneca
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 BioDiem
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 FluGen
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Novavax
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Medicago
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Bharat Biotech
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Serum Institute of India
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Sinovac Biotech
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 CureVac
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Moderna
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Inovio Pharmaceuticals
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Altimmune
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Vaxart
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Dynavax Technologies
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Valneva
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Emergent BioSolutions
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 CSL Limited
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦